161 related articles for article (PubMed ID: 19646655)
1. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.
Giaginis C; Giagini A; Theocharis S
Pharmacol Res; 2009 Sep; 60(3):160-9. PubMed ID: 19646655
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
Abdelrahman M; Sivarajah A; Thiemermann C
Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
[TBL] [Abstract][Full Text] [Related]
3. [PPARgamma as a new therapeutic target in inflammatory diseases].
Naito Y; Yoshikawa T
Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.
Giaginis C; Margeli A; Theocharis S
Expert Opin Investig Drugs; 2007 Oct; 16(10):1561-72. PubMed ID: 17922621
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma in osteoarthritis.
Fahmi H; Martel-Pelletier J; Pelletier JP; Kapoor M
Mod Rheumatol; 2011 Feb; 21(1):1-9. PubMed ID: 20820843
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisome proliferator-activated receptors-gamma (PPAR-gamma) and their role in immunoregulation and inflammation control].
Sokołowska M; Kowalski ML; Pawliczak R
Postepy Hig Med Dosw (Online); 2005; 59():472-84. PubMed ID: 16258412
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator activated receptor-gamma (PPAR-gamma) ligands and angiogenesis.
Margeli A; Kouraklis G; Theocharis S
Angiogenesis; 2003; 6(3):165-9. PubMed ID: 15041792
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Han S; Roman J
Anticancer Drugs; 2007 Mar; 18(3):237-44. PubMed ID: 17264754
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.
Giaginis C; Tsourouflis G; Theocharis S
Curr Mol Med; 2008 Sep; 8(6):562-79. PubMed ID: 18781963
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.
Koufany M; Jouzeau JY; Moulin D
Biomed Mater Eng; 2014; 24(1 Suppl):81-8. PubMed ID: 24928921
[TBL] [Abstract][Full Text] [Related]
12. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis.
Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN
Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story.
François M; Richette P; Corvol MT
Drug News Perspect; 2005 May; 18(4):257-61. PubMed ID: 16034482
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Expert Opin Investig Drugs; 2007 Feb; 16(2):195-207. PubMed ID: 17243939
[TBL] [Abstract][Full Text] [Related]
16. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
Feinstein DL; Spagnolo A; Akar C; Weinberg G; Murphy P; Gavrilyuk V; Dello Russo C
Biochem Pharmacol; 2005 Jul; 70(2):177-88. PubMed ID: 15925327
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
19. The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S; Plumb J; Metcalfe H; Spicer D; Woodman P; Fox JC; Singh D
Eur Respir J; 2014 Feb; 43(2):409-20. PubMed ID: 23794466
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma in malignant diseases.
Wang T; Xu J; Yu X; Yang R; Han ZC
Crit Rev Oncol Hematol; 2006 Apr; 58(1):1-14. PubMed ID: 16388966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
